Skip to main content
Equibles

Creative Planning

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1540235 OVERLAND PARK, KS
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,979,887
+$1,814,417 QoQ
Shares Held
1,240,848
+6.3% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#22
of 238 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Creative Planning holds $137,414,626 across 41 Drug Manufacturers - Specialty & Generic names. RDY ranks #1 (13.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RDY
Dr Reddys Laboratories Ltd
This page 		1,240,848 $17,979,887
2 UTHR
UNITED THERAPEUTICS Corp
 28,934 $15,677,309
3 VTRS
Viatris Inc
 920,607 $14,619,238
4 NBIX
Neurocrine Biosciences Inc
 76,818 $12,946,905
5 LNTH
Lantheus Holdings, Inc.
 85,571 $9,493,246
6 TAK
Takeda Pharmaceutical Co Ltd
 584,777 $9,373,974
7 ZTS
Zoetis Inc.
 121,209 $8,710,078
8 HIMS
Hims & Hers Health, Inc.
 225,206 $7,807,891

All Filings in RDY

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,979,887 1,240,848
2026-03-31 $16,165,470 1,167,182
2025-12-31 $16,318,017 1,162,252
2025-09-30 $17,655,215 1,262,891
2025-06-30 $16,456,827 1,094,932
2025-03-31 $7,044,897 534,109
2024-12-31 $10,041,191 635,921
2024-09-30 $8,303,477 104,512
2024-06-30 $6,668,297 87,522
2024-03-31 $5,234,622 71,365
2023-12-31 $4,014,695 57,699
2023-09-30 $2,380,169 35,594
2023-06-30 $1,863,638 29,530
2023-03-31 $1,208,282 21,224
2022-12-31 $612,357 11,833
2022-09-30 $531,669 10,158
2022-06-30 $201,121 3,631
2021-06-30 $334,470 4,550
2021-03-31 $732,812 11,937
2020-12-31 $1,137,075 15,950
2020-09-30 $339,939 4,887
2020-06-30 $265,845 5,015
2020-03-31 $214,353 5,315